Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS Health Corp.

http://www.cvs.com

Latest From CVS Health Corp.

SVB’s Milo Bissin Predicts ‘Reckoning In 2024’ For Health Care Companies With Sky-High Valuations

VC funding will remain challenging for many in the health care industry, Silicon Valley Bank’s market manager Milo Bissin told attendees at the recent DHIS West conference. Companies focusing on promising areas such as AI-powered technologies, women’s health and value-based care likely have the best chances to draw investors’ attention.

Artificial Intelligence Business Strategies

Blue Shield Of California’s Pharmacy Benefit Overhaul Could Still See Boost From Transparency Legislation

The payor’s multiyear plan to ditch the traditional PBM model and use multiple vendors has drawn a lot of skepticism from other actors in the health care system, but Blue Shield is hoping that it can help give policymakers some momentum, VP Lum tells the Pink Sheet.

Interviews PBMs

340B Investigation: US Sen. Cassidy Expands Probe To Contract Pharmacies, Targeting CVS, Walgreens

Ranking Republican on Senate HELP Committee seeks detailed information on companies’ 340B operations, revenue sources and whether discounts are shared with patients.

Medicaid Reimbursement

CVS Launches Cordavis To Make US Biosimilars More Accessible, Affordable

CVS Health’s new subsidiary Cordavis will help manufacturers produce and/or commercialize biosimilars with the aim of reducing overall drug costs while improving access to and affordability of medicines.

Biosimilars Market Access
See All

Company Information

  • Industry
  • Distributors
  • Services
  • Pharmaceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register